Our patients include professional athletes, weekend warriors, and baby boomers who just want to continue playing pickleball
After reconstitution, stability decreases dramatically
Biological actions and therapeutic potential of the glucagon-like peptides
Another study evaluated BIIB122 (DNL151), a potent and selective LRRK2 inhibitor, which demonstrated dose-dependent LRRK2 inhibition and modulation of the lysosomal pathway in both healthy participants and PD patients
Brief Report: A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of Apilimod Mesylate, an Interleukin-12/Interleukin-23 Inhibitor, in Patients With Rheumatoid Arthritis